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Deletion and substitution mutations affecting the oligomerization of alfalfa mosaic virus (AMV) coat protein (CP) were
studied in protoplasts to determine their effect on genome activation, an early step in AMV replication. The CP mutants that
formed dimers, CPC9 and CPC-ARF, were highly active in initiating replication with 63–84% of wild-type (wt) CP activity.
However, all mutants that did not form dimers, CPC18, CPC19, CPC-WFP, and CPC-W, were much less active with 19–33%
of wt CP activity. The accumulation and solubility of mutant CPs expressed from a virus-based vector in Nicotiana
benthamiana were similar to that of wt CP. Analysis of CP–RNA interactions indicated that CP dimers and CP monomers
interacted very differently with AMV RNA 3 ends. These results suggest that CP dimers are more efficient for replicationg rathe
mutant CPs in infected cells. © 2002 Elsevier Science (USA)
INTRODUCTION
Alfalfa mosaic virus (AMV) coat protein (CP) is a mul-
tifunctional protein. It is involved in (1) virion assembly
(Van Vloten-Doting and Jaspars, 1972; Houwing and Jas-
pars, 1993; Jaspars, 1985); (2) viral cell-to-cell movement
(Dore et al., 1991; Van der Vossen et al., 1994); (3) early
infection termed “genome activation” (Bol et al., 1971);
and (4) viral replication (De Graaff et al., 1995). Dimers of
AMV CP bind to genomic RNAs 1, 2, and 3 and to
subgenomic RNA 4 to assemble bacilliform particles that
contain a single species of RNA (Heijtink and Jaspars,
1976; Heijtink et al., 1977; Van Regenmortel and Pinck,
1981; Houwing and Jaspars, 1982; Francki, 1985). In the
absence of RNA, the CP dimers assemble to T  1
icosahedral particle in vitro (Fukuyama et al., 1981, 1983).
Crystallographic studies (Kumar et al., 1997) suggested
that the C-terminal part of the CP is important for dimer
formation via interactions with partner termini. This was
confirmed in the recent article by Choi and Loesch-Fries
(1999), which showed that deletions and amino acid
substitutions in the C-terminus of the CP interfered with
subunit interaction and particle assembly.
A notable characteristic of AMV CP is that the CP or its
messenger, RNA 4, is required along with the genomic
RNAs to initiate replication (Bol et al., 1971). This distin-
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44guishes it from the bromoviruses and cucumoviruses in
the family of Bromoviridae (Bol et al., 1971; Murphy et el.,
1995). However, the mechanism by which CP initiates
infection is poorly understood. AMV CP binds to the 3
untranslated region (UTR) of all AMV RNAs (Houwing
and Jaspars, 1978, 1982; Baer et al., 1994; Houser-Scott
et al., 1994; Van der Vossen et al., 1994). The RNA-binding
motif in the N-terminus of the CP and the critical nucle-
otides in the 3 UTR involved in binding have been
recently identified (Houser-Scott et al., 1994, 1997; Ansel-
McKinney et al., 1996; Ansel-McKinney and Gehrke,
1998; Van Rossum et al., 1997; Swanson et al., 1998).
Infectivity assays in protoplasts have shown that CP-RNA
binding is critical for genome activation (Yusibov and
Loesch-Fries, 1995a, 1998; Ansel-McKinney et al., 1996).
It was thought that, perhaps, CP–RNA interactions con-
tributed to genome activation by preventing degradation
of the RNAs by nuclease (Neeleman et al., 1993; Tenllado
and Bol, 2000). However, it was shown that AMV
genomic RNAs are quite stable in the cell in the absence
of CP or viral replicase (Houwing and Jaspars, 2000).
Olsthoorn et al. (1999) reported data suggesting that a
pseudoknot conformation of the 3 UTR is required for
AMV ()-strand RNA synthesis and that binding of the
CP to this region switches the conformation to a stable
stem-loop structure (Houwing and Jaspars, 1980; Baer et
al., 1994; Van der Vossen et al., 1994; De Graaff et al.,
1995), thereby promoting ()-strand RNA synthesis and
shutting off ()-strand synthesis. A recent article by
Neeleman et al. (2001) suggests that the CP acts as an
analog of poly(A)-binding protein in promoting translation
of all AMV RNAs, especially RNA1, early in infection.than CP monomers because of differences in RNA bindin
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For both RNA binding and genome activation, the N-
terminus of AMV CP is critical (Bol et al., 1974; Zuidema
et al., 1983 Yusibov and Loesch-Fries, 1995a, 1998). Ad-
ditionally, Baer et al. (1994) showed that a peptide con-
sisting of the first 25 or 38 amino acids of the N-terminus
was sufficient to specifically bind to the RNA and to
initiate AMV replication. Although the N-terminus of the
CP is sufficient for both functions, the full-length CP has
higher activity in genome activation than the peptides
(Baer et al., 1994; Ansel-McKinney et al., 1996; J. Choi and
S. Loesch-Fries, unpublished data). This suggests that
other regions of the CP contribute to genome activation.
In this study, we investigated the effect of C-terminal
deletion and substitution mutations, which do not affect
the core structure of the CP, on genome activation. Thus,
we investigated whether mutations that affected the oli-
gomeric state of the CP affected genome activation.
RESULTS
Mutant CP characterization and activity in genome
activation
The C-terminal CP mutants had been previously char-
acterized by glutaraldehyde cross-linking to determine
subunit interactions (Choi and Loesch-Fries, 1999). The
following two mutants formed dimers: CPC9, which
lacks the last 9 amino acids in the C-terminus of CP; and
CPC-ARF, which has arginine and alanine substitutions at
the position of A196 and F197. However, the other mutants,
including CPC18, which lacks last C-terminal 18 amino
acids; CPC19, which lacks the last 19 amino acids at
the C-terminus, but includes 14 nonviral amino acids at
the C-terminus; CPC-WFP, which has alanine substitu-
tions at the positions of W191, F197, P198; and CPC-W, which
has an alanine substitution at W191, did not form dimers.
To determine the relative activity of the mutants in the
initiation of replication, tobacco protoplasts were in-
fected with AMV RNA 1, 2, and 3 plus transcripts of RNA
4 encoding wild-type (wt) or mutant CPs. The percentage
of protoplasts that become infected is a measure of the
activity of the CP encoded in RNA 4 and has been shown
to correlate with the level of AMV RNA accumulation in
infected cells (Yusibov and Loesch-Fries, 1995b). Inocu-
lation of genomic RNAs alone to protoplasts resulted in
the infection of 3% of the protoplasts due to a small
residual amount of RNA 4 in the inoculum (Fig. 1). When
wt RNA 4 was included with the genomic RNAs, 35% of
the protoplasts were infected. The addition of CPC9 or
CPC-ARF transcripts to the inoculum resulted in 22 or
28% infection rates, respectively (Fig. 1), which are 63 or
84% of wt RNA infection. In contrast, the addition of
transcripts of CPC18, CPC19, CPC-WFP, or CPC-W
resulted in infection of 11, 12, 9, or 6% of the protoplasts
(Fig. 1), which is 19–33% of the wt infection rate.
Accumulation of wt or mutant CPs in tobacco leaves
Although all mutant CPs were translated similarly in
vitro, they behaved differently in Escherichia coli. Mutant
CPs that had low activity in genome activation had low
solubility in E. coli. Therefore, it was possible that the low
activity of mutant CPs in genome activation was due to
problems in protein expression in plant cells. To deter-
mine whether this was the case, selected mutants were
expressed in Nicotiana benthamiana plants using a to-
bacco mosaic virus (TMV)-based vector (TB2) (Donson et
al., 1991). Inoculation of transcripts of the TB2 vector
alone or transcripts of TB2 containing wt or mutant AMV
CP genes caused severe mosaic and leaf distortion 2–3
weeks postinoculation (data not shown). Figure 2 shows
that all CPs accumulated in leaf tissue and that similar
amounts of wt and mutant CPs were detected. Wt CP
was present in both insoluble and soluble fractions.
Likewise, CPC-W, CPC-ARF, and CPC19 were present in
both fractions. Analysis of several independent experi-
ments showed no significant differences in the accumu-
lation of wt and mutant CPs in tobacco leaves.
AMV CP–RNA interaction
All CP mutants contained an intact wt N-terminus,
which is critical for binding to the 3 UTR of genomic
AMV RNAs and activating infection, suggesting that all
mutants should interact with AMV RNA. However, elec-
trophoretic mobility shift analysis (EMSA) showed that
there were differences in the binding behaviors of the
mutants (Fig. 3). Incubation of 32P-labeled AMV 3 UTR
with CP translated from wt RNA 4 resulted in two bands
above the free RNA band (Figs. 3A and 3B). (The number
FIG. 1. The activity of wt and mutant AMV CPs in the initiation of
replication. Genomic AMV RNA (RNA 1, 2, and 3) was mixed with RNA
transcripts encoding wt or mutant AMV CP and inoculated to tobacco
protoplasts. The percentage of infected protoplasts in each sample
was determined by an immunoassay 24 h after infection. The bars,
which are labeled with the CP transcript added to the inoculum,
indicate the percentage of infected protoplasts for each sample; ()
indicates that the inoculum did not contain a CP transcript, but only
genomic RNAs. The error bars indicate standard deviations for at least
five independent experiments.
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of CP–RNA complexes that can be detected depends
critically on the concentration of protein in the reaction
mixture.) Complexes were not detected when the RNA
was incubated with brome mosaic virus (BMV) CP or
CP18A, which had previously been shown to lack the
ability to bind to AMV RNA (Yusibov and Loesch-Fries,
1998). Incubation of CPC-ARF with RNA resulted in a
band at a position similar to the major wt CP-RNA band
(Fig. 3A), while incubation of CPC9 with RNA resulted in
a band of slightly higher mobility, presumably resulting
from a more compact structure due to deletion of 9
amino acids (Fig. 3A). In contrast, similar band shifts
were not detected when CPC18, CPC-WFP, or CPC-W
synthesized in vitro were incubated with RNA under
similar conditions (Fig. 3A). However, as shown in Fig.
3B, addition of higher concentrations of CPC18 or
CPC-W resulted in broad areas of radioactivity in the gel
lanes and significant amounts in the wells, indicating the
formation of high molecular weight complexes between
CP monomers and the 3 UTR (Fig. 3B). However, neither
CPC18 nor CPC-W significantly interfered with wt CP
binding in competition assays, as shown for CPC18 in
Fig. 3C. When increasing amounts of CPC18 were
added to EMSA reactions containing wt CP, the two
bands consisting of wt CP–RNA complexes were largely
unaffected, whereas increasing the amount of wt CP in
EMSA reactions containing CPC18 resulted in the for-
mation of more of the higher molecular weight CP-RNA
band, as expected.
DISCUSSION
The goal of this study was to determine whether the
oligomeric state of AMV CP affected its activity in ge-
nome activation. The C-terminal mutant CPs fell into two
classes. One class, included CPC-ARF and CPC9,
which had relatively high activity in genome activation.
These CPs formed dimers, assembled into particles, and
were well expressed in E. coli in a soluble form that was
easy to purify (Choi and Loesch-Fries, 1999). The other
FIG. 2. Western blot analysis of AMV CP accumulation in N.
benthamiana. Leaves were inoculated with transcripts of the TB2 se-
ries expressing different CP mutants. Tissue was collected 2–3 weeks
after inoculation and homogenized for assay of total protein or for
soluble and insoluble proteins by PAGE electrophoresis and immuno-
blotting. The specific TB2 transcript used for inoculation of each sam-
ple is indicated above the lines; T, S, and P below the lines indicate
total protein, soluble protein, and insoluble protein in the pellet, re-
spectively. The positions of molecular weight markers are indicated at
the right.
FIG. 3. EMSA of CP-RNA complexes. The 3 UTR of RNA4 was transcribed from pSP65A4, labeled with [32P]UTP in vitro, and incubated with wt or
mutant CP synthesized in vitro. The RNA–CP complexes were separated in a 7.5% native polyacrylamide gel and detected by autoradiography. Gel
lanes are labeled with the specific CP included in the reaction; small circles indicate the positions of protein–RNA complexes, and diamonds indicate
the positions of free AMV RNA. (A) Labeled RNA was incubated with wt CP translated from AMV RNA4 isolated from virions (CP*) or with a translation
mixture containing wt or mutant CP at 0.1 pmol RNA:0.5 pmol protein. Control samples included RNA incubated with the following: a purified
translation reaction to which no mRNA was added (), brome mosaic virus CP translated in vitro (BMV CP), an AMV N-terminal mutant CP, which
had an alanine substitution at position R18 (CP18A), and RNA with no added protein (Free). (B) Labeled RNA (0.1 pmol) was incubated with increasing
concentrations of CPC18 or CPC-W (0.5, 1.0, 2.0, or 5.0 pmol from left to right), as indicated by the triangles above the gel lanes. The first lane
contains RNA (0.1 pmol) and wt CP (0.5 pmol). (C) Labeled RNA (0.1 pmol) was incubated with a constant amount of wt CP (1.0 pmol) and increasing
amounts of CPC18 (0.5, 1.0, or 2.0 pmol) in the first three lanes, or with a constant amount of CPC18 (1.0 pmol) and increasing amounts of wt CP
(0.5, 1.0, or 2.0 pmol) in the last three lanes.
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class included CPC18, CPC19, CPC-WFP, and CPC-W,
which all had relatively low activity. These mutants did
not dimerize, nor assemble, and were poorly expressed
in a soluble form in E. coli (Choi and Loesch-Fries, 1999).
We identified neither mutants with low activity that
formed dimers nor mutants with high activity that failed to
dimerize. This is in contrast to the recent article by
Tenllado and Bol (2000), which described CP mutations
that reduced or abolished CP–CP interactions in a yeast
two-hybrid system, but that had little effect on genome
activation. It is likely that the discrepancies are due to
the use of different assay systems to determine dimer-
ization and infection.
Our mutants described here had alanine substitutions
or deletions in the C-terminal arm, which do not interfere
with the core structure of the CP according to crystallog-
raphy studies (Kumar et al., 1997). Thus, all our mutants
should have retained the core -barrel structure of wt CP
along with a wt N-terminus. When the mutants were
expressed in plants, nearly similar amounts of wt and
mutant CPs accumulated in soluble form. Thus, our re-
sults indicate that the low activity of AMV CP monomers
in replication was not due to poor expression of the
mutants in plant cells. Recently, Bol and colleagues (Van
der Vossen et al., 1994; Tenllado and Bol, 2000) sug-
gested that the low activity of one of their CP mutants,
which is similar to CPC19, was due to impaired stability.
However, our results presented here suggest otherwise
as do the results of Yusibov and Loesch-Fries (1995b),
who reported that CPC19 was well expressed in to-
bacco protoplasts.
Recent studies suggest that AMV CP–RNA interac-
tions are important in genome activation (Yusibov and
Loesch-Fries, 1995a, 1998; Ansel-McKinney et al., 1996).
Accordingly, we found that mutant CPs, which form
dimers, bind to AMV RNA, as expected from previous
studies with wt CP (Baer et al., 1994; Ansel-McKinney et
al., 1996; Yusibov and Loesch-Fries, 1998). In contrast,
the monomer mutants did not interact with the AMV RNA
to form specific complexes that could be detected as
discrete band shifts in EMSA. Rather, the interaction
resulted in diffuse bands in the gel, which migrated
differently than wt CP–RNA complexes and a high con-
centration of complexes remained at the top of the gel.
This indicates that monomer CPs interact very differently
with RNA than do wt CP and the dimer mutants, although
all have an intact N-terminus. Perhaps the dimer confor-
mation optimizes the geometry of the N-terminus so that
it binds to AMV RNA in a way that efficiently activates
infection, whereas CP monomers bind less optimally
with RNA, resulting in low activity. We speculate that, in
addition to the N-terminus, the interface of CP dimers is
involved in RNA interactions similar to flock house virus
and MS2, in which the CP subunit interface–RNA inter-
action is important for particle morphology (Fisher and
Johnson, 1993; Dong et al., 1998; Ni et al., 1995). The
bacilliform structure of native AMV particles suggests
that the CP subunits in the cylindrical portion of the
particle contact the RNA. This contact likely changes the
curvature of the dimer interface from bent to flat, resulting in
the formation of hexamers rather than pentamers, which
are at the ends of the bacilliform particles and which,
presumably, interact little with the RNA (Fukuyama et al.,
1981). Our results show that the C-terminus is important for
dimerization and that CP dimers have more specific inter-
action with AMV RNA than CP monomers.
The requirement of specific CP–RNA interactions for
infection, however, does not elucidate the mechanism of
action of the CP early in infection. It has been reported
that the CP is a component of the AMV RdRp complex
(Quadt et al., 1991) and that CP stimulates plus-strand
RNA synthesis from minus-strand RNA templates, al-
though the amount of stimulation varied greatly between
the results of De Graaff et al. (1995) and Houwing et al.
(2001). Thus, CP–RNA interactions may be important in
early infection for formation of the RdRp containing the
CP and then for the switch from ()-strand RNA synthe-
sis to ()-strand synthesis. Recent reports suggest that
AMV CP induces a conformational change in the 3 UTR,
which may be responsible for the switch to progeny RNA
synthesis (Baer et al., 1994; Olsthoorn et al., 1999). Per-
haps the RdRp complex with CP dimers is more active
than that with CP monomers. It is also possible that a
genomic 3 UTR bound by CP dimers has a better con-




To clone C-terminal mutants of the AMV CP gene into
pSP65A4 (Loesch-Fries et al., 1985), which contains a
full-length cDNA of AMV RNA4, cDNA fragments contain-
ing C-terminal mutations (C9, C18, C-WFP, C-W, and
C-ARF) replaced wt cDNA fragments in pSP65A4. cDNA
fragments of the AMV CP gene containing mutations
were generated by PCR using the primers and the
pSP65A4 template as described by Choi and Loesch-
Fries (1999) and were cloned into pGEM-T (Promega),
resulting the pGEM-T series plasmids. cDNA fragments
containing C-terminal mutations were exchanged with
the corresponding wt fragment in pSP65A4 (Fig. 4), re-
sulting in the pSP65 series of plasmids, which had C-
terminal amino acid sequences described by Choi and
Loesch-Fries (1999). Construction of CPC19 was de-
scribed by Yusibov and Loesch-Fries (1995b).
For expression of the mutant CPs in tobacco, C19,
C-W, and C-ARF in the pSP65A4 series vectors were
cloned into the TB2 vector (Donson et al., 1991). The
EcoRI-RsaI fragment from the pSP65 series of plasmids,
which contained a wt or mutant CP gene, was inserted
into the XhoI site of the TB2 vector by blunt-end cloning
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procedures (Fig. 4), resulting in the TB2 series of plas-
mids.
In vitro transcription
To make run-off transcripts in vitro, DNA of the pSP65
series of plasmids, linearized by SmaI, and DNA of the TB2
series of plasmids, linearized by KpnI, were used as tem-
plates for transcription using SP6 or T7 RNA polymerase
(Promega), respectively. Transcripts were capped with
[m7G(5)ppp(5)G] (New England Biolab) during transcrip-
tion.
Preparation, inoculation, and assay of protoplasts
Protoplasts isolated from Nicotiana tobacum var. xan-
thi-nc were inoculated with 0.5 g genomic RNA (RNAs
1, 2, and 3) and 5 g wt or mutant RNA 4 transcript
(Samac et al., 1983). The protoplasts were collected 24 h
after inoculation, and the percentage of infected proto-
plasts was determined using an immunofluorescent as-
say to detect wt CP (Loesch-Fries and Hall, 1980).
Expression and assay of AMV CP in N. benthamiana
Two young leaves of a N. benthamiana plant were
mechanically inoculated with in vitro RNA transcripts
from the pTB2 series of plasmids at about 50 g per leaf.
Tissue samples were taken from an uninoculated young
leaf showing severe symptoms on each plant 2–3 weeks
postinoculation. Total proteins were extracted from one
disc (diameter, 1 cm) by homogenization in urea buffer (6
M urea, 2% -mercaptoethanol, 0.02% bromphenol blue,
0.05 M Tris–HCl, pH 6.8). Soluble and insoluble proteins
were separated by homogenizing one disc in 10 mM
potassium chloride, 5 mM magnesium chloride, 0.4 M
sucrose, 10% glycerol, 2% -mercaptoethanol, 100 mM
Tris–HCl, pH 8.1 (Berna et al., 1986), followed by centrif-
ugation at 13,000 g for 5 min. Proteins in the supernatant
(soluble proteins) were mixed with an equal volume of
2 urea buffer; proteins in the pellet were solubilized by
homogenization with urea buffer. Proteins in all samples
were separated by SDS–PAGE and AMV CPs were de-
tected by Western blot analysis using monoclonal anti-
bodies against AMV CP.
Electrophoretic mobility shift assay
Transcripts containing nucleotides 718–881 of RNA 4
were transcribed and labeled with [32P]UTP using SP6
RNA polymerase and gel purified. Wt or mutant AMV CPs
were synthesized by in vitro translation using a wheat-
germ system (Promega) and purified by ion exchange
chromatography using DEAE Bio-Gel A (Sigma) as de-
scribed by Baer et al. (1994). RNA transcripts were incu-
bated for 30 min with AMV CP at 0.1:0.5 pmol, plus 1 g
tRNA:0.5 pmol protein as competitor for nonspecific bind-
ing, followed by electrophoretic analysis in a 7.5% native
polyacrylamide gel (acrylamide:bis ratio of 46:1) using
0.5 TBE (44.5 mM Tris, 44.5 mM boric acid, 1.25 mM
EDTA, pH 8.3) at a constant voltage of 100 V followed by
autoradiography.
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